You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD16A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Valencia (AFM28)

Recruiting
  • Acute Myeloid Leukemia
  • Valencia, Spain
    Hospital Universitari i Politècnic La Fe
Apr 5, 2023

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

Refractory or Relapsed B Cell Lymphoma Trial in Chongqing (ThisCART19A, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Refractory or Relapsed B Cell Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 8, 2023

Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

Recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +9 more
  • Anti-CD30/CD16A Monoclonal Antibody AFM13
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Acute Myeloid Leukemia (AML) Relapse Trial in Freiburg, Münster (F16IL2, BI 836858)

Completed
  • Acute Myeloid Leukemia (AML) Relapse
  • Freiburg, Germany
  • +1 more
Apr 13, 2022

Kidney Transplantation, CMV Infection Trial in Bordeaux (Cytotect)

Recruiting
  • Kidney Transplantation
  • CMV Infection
  • Bordeaux, France
    Hopital Pellegrin
Nov 18, 2021

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

Not yet recruiting
  • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 28, 2022

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial (ThisCART19A, Fludarabine Oral Tablet, Cyclophosphamide)

Not yet recruiting
  • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
  • (no location specified)
Oct 8, 2022

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

Recruiting
  • B-cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical College of Zhejiang Uni
May 17, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma

Not yet recruiting
  • Double-Expressor Lymphoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)

Terminated
  • Merkel Cell Carcinoma
  • Avelumab
  • +2 more
  • San Francisco, California
  • +4 more
Jan 7, 2022

Anemia, Sickle Cell Trial in Duarte (Autologous enriched CD34+ cell fraction that contains CD34+ cells transduced with

Terminated
  • Anemia, Sickle Cell
  • Autologous enriched CD34+ cell fraction that contains CD34+ cells transduced with lentiviral vector encoding human γ-globinG16D and short-hairpin RNA734
  • Duarte, California
    City of Hope Medical Center
Jun 14, 2021

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023

HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,

Recruiting
  • HER2-positive Breast Cancer
  • +4 more
  • Essen, Germany
  • +5 more
Nov 15, 2022

Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)

Active, not recruiting
  • Recurrent Adult Hodgkin Lymphoma
  • basiliximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Health Status of Children Born After Assisted Reproductive

Recruiting
  • Children Born After Assisted Reproductive Technologies
  • +2 more
  • hemogram examination
  • Almaty, Kazakhstan
    Sevara ilmuratova
Oct 17, 2023

Dengue Fever, Dengue Hemorrhagic Fever, Dengue Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:

Completed
Has Results
  • Dengue Fever
  • +2 more
  • Live, attenuated, dengue serotype 1, 2, 3, 4 virus
  • Placebo: (NaCl) 0.9% solution
  • Fortaleza, CE, Brazil
  • +21 more
Mar 10, 2022

Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

Not yet recruiting
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +21 more
  • Biopsy
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 7, 2023